Application of fibrin in drug technology: Achievements and perspectives

Author:

Rech Jakub1,Wilińska Justyna2,Borecka Aleksandra3,Turek Artur4

Affiliation:

1. Zakład Biotechnologii i Inżynierii Genetycznej, Wydział Nauk Farmaceutycznych w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach

2. Katedra i Zakład Biofarmacji, Wydział Nauk Farmaceutycznych w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach

3. Centrum Materiałów Polimerowych i Węglowych, Polska Akademia Nauk, Zabrze

4. 2Katedra i Zakład Biofarmacji, Wydział Nauk Farmaceutycznych w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach

Abstract

In recent years, fibrin has been successfully used as a polymer drug delivery carrier. Passive properties of fibrin provide parenteral and local delivery of drug substances in controlled and prolonged manner and also tissue support, gluing and sealing. Fibrin also has hemostatic and proangiogenic effects. Discs, films, gels, beads and nanoparticles are among the most commonly proposed and used fibrin-based formulations. It is routinely obtained from fibrinogen and thrombin. Fibrin formulation methods are solution casting, dual syringe systems and emulsification. All fibrin formulations become gel after administration and water absorption. Biodegradation and biocompatibility are important advantages of fibrin, which make it possible to implant a formulation without the need to remove the carrier from the body after the drug is released. Fibrin-based drug delivery systems are proposed and applied in the treatment of wounds, infections and cancerous diseases.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Reference47 articles.

1. Ahmad E., Fatima M.T., Hoque M., Owais M., Saleemuddin M.:Fibrin matrices: The versatile therapeutic delivery systems. Int. J.Biol. Macromol., 2015; 81: 121–136

2. Ahmad E., Fatima M.T., Owais M., Saleemuddin M.: Beaded plasmaclot: A potent sustained-release, drug-delivery system. Ther.Deliv., 2011; 2: 573–583

3. Alphonsa B.M., Sudheesh Kumar P.T., Praveen G., Biswas R.,Chennazhi K.P., Jayakumar R.: Antimicrobial drugs encapsulatedin fibrin nanoparticles for treating microbial infested wounds.Pharm. Res., 2014; 31: 1338–1351

4. Anai S., Hide T., Takezaki T., Kuroda J., Shinojima N., Makino K.,Nakamura H., Yano S., Kuratsu J.: Antitumor effect of fibrin gluecontaining temozolomide against malignant glioma. Cancer. Sci.,2014; 105: 583–591

5. Brown A.C., Barker T.H.: Fibrin-based biomaterials: Modulationof macroscopic properties through rational design at the molecularlevel. Acta Biomater., 2014; 10: 1502–1514

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3